相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Establishment of multiplexed, microsphere-based flow cytometric assay for multiple human tumor markers
Kai Sun et al.
ACTA PHARMACOLOGICA SINICA (2007)
Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis
Nirmal K. Banda et al.
JOURNAL OF IMMUNOLOGY (2006)
Monocyte surface-bound IL-15 can function as an activating receptor and participate in reverse signaling
GG Neely et al.
JOURNAL OF IMMUNOLOGY (2004)
Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis
MA Hietala et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Activated protein C in sepsis: emerging insights regarding its mechanism of action and clinical effectiveness
M Haley et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2004)
Expression and function of the endothelial protein C receptor in human neutrophils
DH Sturn et al.
BLOOD (2003)
The enigma of sepsis
NC Riedemann et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Therapeutic approaches to innate immunity: Severe sepsis and septic shock
E Lolis et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Endothelial protein C receptor-dependent inhibition of human eosinophil chemotaxis by protein C
C Feistritzer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice
E Saeland et al.
JOURNAL OF IMMUNOLOGY (2003)
Activated protein C inhibits the expression of platelet-derived growth factor in the lung
S Shimizu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Novel strategies for the treatment of sepsis
NC Riedemann et al.
NATURE MEDICINE (2003)
Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice
JM Thurman et al.
JOURNAL OF IMMUNOLOGY (2003)
Critical role of the complement system in group B Streptococcus-induced tumor necrosis factor alpha release
O Levy et al.
INFECTION AND IMMUNITY (2003)
Endotoxin as a drug target
SM Opal et al.
CRITICAL CARE MEDICINE (2003)
Pharmacokinetic-pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis
WL Macias et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Protection of innate immunity by C5aR antagonist in septic mice
MS Huber-Lang et al.
FASEB JOURNAL (2002)
Complement factor B gene regulation:: Synergistic effects of TNF-α and IFN-γ in macrophages
Y Huang et al.
JOURNAL OF IMMUNOLOGY (2002)
Complement deficiency ameliorates collagen-induced arthritis in mice
MA Hietala et al.
JOURNAL OF IMMUNOLOGY (2002)
Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-κB
DE Joyce et al.
CRITICAL CARE MEDICINE (2002)
Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis
DE Joyce et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Role of C5a in multiorgan failure during sepsis
M Huber-Lang et al.
JOURNAL OF IMMUNOLOGY (2001)
Attenuation of experimental autoimmune demyelination in complement-deficient mice
S Nataf et al.
JOURNAL OF IMMUNOLOGY (2000)
Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor κB (NF-κB) and tumour necrosis factor α (TNF-α) production in the THP-1 monocytic cell line
B White et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B
H Watanabe et al.
JOURNAL OF IMMUNOLOGY (2000)